Kobayashi EH, Suzuki T, Funayama R, Nagashima T, Hayashi M, Sekine H, et al
The total lysate was collected from 3 wells of a 6-well plate containing Reporter lysis buffer, 16 U/L RNase inhibitor, and protease inhibitor
Taking these facts into consideration, the Food and Drug Administration (FDA) recommended that in order to establish the safety of a new antidiabetic therapy for T2DM, the manufacturers or sponsors should demonstrate that the new drug will not result in an unacceptable increase in cardiovascular risk and the trials population should also include high risk patients
Options may include phentermine-topiramate, a combination medication that suppresses appetite, as well as medications originally approved for other conditions, such as the antidepressant bupropion (Wellbutrin) or the diabetes drug metformin